Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-10 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
641,887,034
Market Cap (USD)
450,279,569
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63%
Free-Float capitalization (CAD)
363,483,187
Free-Float capitalization (USD)
254,981,085
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 450M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.91B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.13B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.79B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 29.31B | |
| +2.33% | -5.69% | -27.28% | +338.00% | 23.71B | |
| Average | +0.03% | -0.79% | +52.17% | +159.40% | 39.29B | |
| Weighted average by Cap. | +0.24% | -0.98% | +57.35% | +150.73% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
